Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 245

1.

Dopamine signaling in reward-related behaviors.

Baik JH.

Front Neural Circuits. 2013 Oct 11;7:152. doi: 10.3389/fncir.2013.00152. Review.

2.
3.

Dopamine signaling through D1-like versus D2-like receptors in the nucleus accumbens core versus shell differentially modulates nicotine reward sensitivity.

Laviolette SR, Lauzon NM, Bishop SF, Sun N, Tan H.

J Neurosci. 2008 Aug 6;28(32):8025-33. doi: 10.1523/JNEUROSCI.1371-08.2008.

4.

Inputs from the basolateral amygdala to the nucleus accumbens shell control opiate reward magnitude via differential dopamine D1 or D2 receptor transmission.

Lintas A, Chi N, Lauzon NM, Bishop SF, Sun N, Tan H, Laviolette SR.

Eur J Neurosci. 2012 Jan;35(2):279-90. doi: 10.1111/j.1460-9568.2011.07943.x.

PMID:
22236063
5.

Evidence of increased dopamine receptor signaling in food-restricted rats.

Carr KD, Tsimberg Y, Berman Y, Yamamoto N.

Neuroscience. 2003;119(4):1157-67.

PMID:
12831870
6.

Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.

Salamone JD, Correa M, Farrar A, Mingote SM.

Psychopharmacology (Berl). 2007 Apr;191(3):461-82. Review.

PMID:
17225164
7.

Neural mechanisms of the nucleus accumbens circuit in reward and aversive learning.

Hikida T, Morita M, Macpherson T.

Neurosci Res. 2016 Jul;108:1-5. doi: 10.1016/j.neures.2016.01.004. Review.

PMID:
26827817
8.

Dopamine and drug addiction: the nucleus accumbens shell connection.

Di Chiara G, Bassareo V, Fenu S, De Luca MA, Spina L, Cadoni C, Acquas E, Carboni E, Valentini V, Lecca D.

Neuropharmacology. 2004;47 Suppl 1:227-41. Review.

PMID:
15464140
9.
11.

Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary.

Blum K, Chen AL, Chen TJ, Braverman ER, Reinking J, Blum SH, Cassel K, Downs BW, Waite RL, Williams L, Prihoda TJ, Kerner MM, Palomo T, Comings DE, Tung H, Rhoades P, Oscar-Berman M.

Theor Biol Med Model. 2008 Nov 12;5:24. doi: 10.1186/1742-4682-5-24. Review.

13.

Localization of dopamine D2 receptors on cholinergic interneurons of the dorsal striatum and nucleus accumbens of the rat.

Alcantara AA, Chen V, Herring BE, Mendenhall JM, Berlanga ML.

Brain Res. 2003 Oct 3;986(1-2):22-9.

PMID:
12965226
14.
15.

Aversive behavior induced by optogenetic inactivation of ventral tegmental area dopamine neurons is mediated by dopamine D2 receptors in the nucleus accumbens.

Danjo T, Yoshimi K, Funabiki K, Yawata S, Nakanishi S.

Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6455-60. doi: 10.1073/pnas.1404323111.

16.

Cholinergic modulation of mesolimbic dopamine function and reward.

Mark GP, Shabani S, Dobbs LK, Hansen ST.

Physiol Behav. 2011 Jul 25;104(1):76-81. doi: 10.1016/j.physbeh.2011.04.052. Review.

17.
18.

Pathway-specific modulation of nucleus accumbens in reward and aversive behavior via selective transmitter receptors.

Hikida T, Yawata S, Yamaguchi T, Danjo T, Sasaoka T, Wang Y, Nakanishi S.

Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):342-7. doi: 10.1073/pnas.1220358110.

19.

In vivo imaging identifies temporal signature of D1 and D2 medium spiny neurons in cocaine reward.

Calipari ES, Bagot RC, Purushothaman I, Davidson TJ, Yorgason JT, Peña CJ, Walker DM, Pirpinias ST, Guise KG, Ramakrishnan C, Deisseroth K, Nestler EJ.

Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2726-31. doi: 10.1073/pnas.1521238113.

20.

Reward system and addiction: what dopamine does and doesn't do.

Di Chiara G, Bassareo V.

Curr Opin Pharmacol. 2007 Feb;7(1):69-76. Review. Erratum in: Curr Opin Pharmacol. 2007 Apr;7(2):233.

PMID:
17174602
Items per page

Supplemental Content

Support Center